174 related articles for article (PubMed ID: 33277773)
1. Flow cytometry-based analysis of tumor-leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer.
Takahashi K; Kurashina K; Saito S; Kanamaru R; Ohzawa H; Yamaguchi H; Miyato H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Cytometry B Clin Cytom; 2021 Nov; 100(6):666-675. PubMed ID: 33277773
[TBL] [Abstract][Full Text] [Related]
2. Flow Cytometric Quantification of Intraperitoneal Free Tumor Cells is a Useful Biomarker in Gastric Cancer Patients with Peritoneal Metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Onoyama H; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Ann Surg Oncol; 2015 Jul; 22(7):2336-42. PubMed ID: 25404476
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Cytometry B Clin Cytom; 2014 Jan; 86(1):56-62. PubMed ID: 24115348
[TBL] [Abstract][Full Text] [Related]
4. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer.
Takahashi K; Kurashina K; Yamaguchi H; Kanamaru R; Ohzawa H; Miyato H; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
Front Immunol; 2022; 13():969468. PubMed ID: 36119051
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric quantification of intraperitoneal free tumor cells (FTC) in patients with peritoneal metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Cytometry B Clin Cytom; 2013 Aug; ():. PubMed ID: 24038963
[TBL] [Abstract][Full Text] [Related]
6. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
7. Effect of Systemic or Intraperitoneal Administration of Anti-PD-1 Antibody for Peritoneal Metastases from Gastric Cancer.
Kumagai Y; Futoh Y; Miyato H; Ohzawa H; Yamaguchi H; Saito S; Kurashina K; Hosoya Y; Lefor AK; Sata N; Kitayama J
In Vivo; 2022; 36(3):1126-1135. PubMed ID: 35478147
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry detection of cell type-specific expression of programmed death receptor ligand-1 (PD-L1) in colorectal cancer specimens.
Saito A; Tojo M; Kumagai Y; Ohzawa H; Yamaguchi H; Miyato H; Sadatomo A; Naoi D; Ota G; Koinuma K; Horie H; Lefor AK; Sata N; Kitayama J
Heliyon; 2021 Jan; 7(1):e05880. PubMed ID: 33458446
[TBL] [Abstract][Full Text] [Related]
9. Immunological milieu in the peritoneal cavity at laparotomy for gastric cancer.
Yoneda A; Ito S; Susumu S; Matsuo M; Taniguchi K; Tajima Y; Eguchi S; Kanematsu T; Nagata Y
World J Gastroenterol; 2012 Apr; 18(13):1470-8. PubMed ID: 22509078
[TBL] [Abstract][Full Text] [Related]
10. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
11. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
Risberg B; Davidson B; Dong HP; Nesland JM; Berner A
J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174
[TBL] [Abstract][Full Text] [Related]
12. CD45
Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
[TBL] [Abstract][Full Text] [Related]
13. High CD8/CD33 ratio in peritoneal metastatic lesions is associated with favorable prognosis in gastric cancer.
Yamaguchi T; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Makino I; Nakamura K; Tajima H; Ninomiya I; Fushida S
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1389. PubMed ID: 33793095
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal cytology in the surgical evaluation of gastric carcinoma.
Hayes N; Wayman J; Wadehra V; Scott DJ; Raimes SA; Griffin SM
Br J Cancer; 1999 Feb; 79(3-4):520-4. PubMed ID: 10027323
[TBL] [Abstract][Full Text] [Related]
15. Separation and single-cell analysis for free gastric cancer cells in ascites and peritoneal lavages based on microfluidic chips.
Zhao J; Han Z; Xu C; Li L; Pei H; Song Y; Wang Z; Tang B
EBioMedicine; 2023 Apr; 90():104522. PubMed ID: 36933411
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
[TBL] [Abstract][Full Text] [Related]
17. Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer.
Fujimori D; Kinoshita J; Yamaguchi T; Nakamura Y; Gunjigake K; Ohama T; Sato K; Yamamoto M; Tsukamoto T; Nomura S; Ohta T; Fushida S
BMC Cancer; 2020 Oct; 20(1):1014. PubMed ID: 33081727
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
Ohzawa H; Saito A; Kumagai Y; Kimura Y; Yamaguchi H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Oncol Rep; 2020 Apr; 43(4):1081-1088. PubMed ID: 32323853
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
20. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric Cancer.
Ohzawa H; Kimura Y; Saito A; Yamaguchi H; Miyato H; Sakuma Y; Horie H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Ann Surg Oncol; 2020 Dec; 27(13):5057-5064. PubMed ID: 32804324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
